Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
835.6 INR | +1.12% | +9.13% | +21.46% |
May. 30 | India's Apollo Hospitals misses Q4 profit estimates on higher expenses | RE |
May. 24 | Jefferies Adjusts Max Healthcare’s Price Target to INR940 From INR915, Keeps at Buy | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
Strengths
- The prospective high growth for the next fiscal years is among the main assets of the company
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The group's activity appears highly profitable thanks to its outperforming net margins.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Analyst opinion has improved significantly over the past four months.
Weaknesses
- With an expected P/E ratio at 61.23 and 51.86 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Healthcare Facilities & Services
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+21.46% | 9.62B | B- | ||
+24.66% | 88.38B | C+ | ||
-21.76% | 77.56B | B- | ||
+8.45% | 26.97B | C+ | ||
+7.94% | 18.45B | A- | ||
-13.50% | 16.57B | B | ||
+77.51% | 13.65B | C- | ||
+76.96% | 13.06B | C+ | ||
+4.72% | 12.61B | A- | ||
+36.67% | 12.56B | B- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- MAXHEALTH Stock
- Ratings Max Healthcare Institute Limited